The World Health Organization (WHO) has recommended a targeted vaccination strategy over mass vaccination to manage the spread of the mpox virus, emphasizing that controlling the virus is more feasible than the challenges posed by COVID-19.
Margaret Harris, a spokesperson for the WHO, highlighted the recent rise in mpox cases, particularly due to a new strain known as Clade 1b, which emerged last year. This strain is noted for its rapid transmission and a higher fatality rate, particularly among children. In an interview with Anadolu, Harris explained that mpox, which has two genetic types—Clade 1 and Clade 2—has seen a concerning increase in cases in 2024.
The surge has extended beyond the eastern regions of the Democratic Republic of Congo to neighboring countries such as Burundi, Rwanda, Uganda, and Kenya. The overall fatality rate stands at approximately 3%, with small children and other vulnerable groups at even greater risk.
To combat the spread, the WHO has advised that individuals exposed to mpox receive the smallpox vaccine within four days of exposure. This recommendation is particularly important for healthcare workers in high-risk areas. Harris emphasized that, despite the severity of the virus, it can be effectively managed through timely identification, contact tracing, and isolation of infected individuals.
Addressing concerns about the potential for mpox to become a global pandemic, Harris reassured that the virus primarily spreads through close physical contact, rather than airborne transmission, making it easier to control than COVID-19. Consequently, she stated that lockdowns are not necessary. However, Harris underscored the importance of robust surveillance and laboratory diagnostics to prevent a wider outbreak.
Harris also stressed the need for transparency in reporting cases, citing recent detections of mpox in countries like Pakistan and Sweden. She emphasized that transparent communication from these countries is vital to global efforts in combating the virus.
The WHO’s approach focuses on targeted intervention to contain the virus while minimizing disruption to daily life. By prioritizing vaccination for exposed individuals and ensuring swift action in high-risk areas, the organization believes that the spread of mpox can be controlled effectively without resorting to drastic measures such as lockdowns, which were necessary during the COVID-19 pandemic.
